Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 8038351)

Published in Aliment Pharmacol Ther on April 01, 1994

Authors

S Hurlimann1, B Abbühl, W Inauen, F Halter

Author Affiliations

1: Gastrointestinal Unit, University Hospital, Inselspital Bern, Switzerland.

Articles by these authors

Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol (1996) 2.08

Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am J Physiol (1989) 1.65

Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat. Gastroenterology (1988) 1.50

Removal of razor blades from stomach with fibreoptic endoscope. Br Med J (1974) 1.50

Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol (1998) 1.44

Self-expanding metal stents in malignant esophageal obstruction: a comparison between two stent types. Am J Gastroenterol (1997) 1.42

[Collagen colitis and lymphocytic (microscopic) colitis: different or common origin?]. Z Gastroenterol (1997) 1.41

Detection and prevalence of Helicobacter infection in pet cats. J Clin Microbiol (1998) 1.29

Gastric and duodenal ulcer healing under placebo treatment. Gastroenterology (1977) 1.23

Evaluation of specific value of endoscopic biopsies and brush cytology for malignancies of the oesophagus and stomach. Gut (1976) 1.18

Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol (1995) 1.18

Influence of long-term 16,16-dimethyl prostaglandin E2 treatment on the rat gastrointestinal mucosa. Gastroenterology (1983) 1.16

Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut (1998) 1.11

Effects of prolonged metiamide medication on the fundic mucosa. A secretory and histomorphometric study in the rat. Gastroenterology (1977) 1.11

Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical? Hepatogastroenterology (1992) 1.09

Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol (1999) 1.06

HGF triggers activation of the COX-2 gene in rat gastric epithelial cells: action mediated through the ERK2 signaling pathway. FASEB J (1999) 1.05

Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats. Gastroenterology (1997) 1.02

[Nonsteroidal antirheumatic drugs and acetylsalicylic acid: adverse effects distal to the duodenum]. Schweiz Med Wochenschr (1996) 1.00

Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical. Am J Physiol (1989) 0.98

Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach. Gastroenterology (1997) 0.97

[Tumors and eosinophilic granuloma of the small intestine in malabsorption]. Schweiz Med Wochenschr (1974) 0.97

Combined surgical and interventional radiological approach for complex benign biliary tract obstruction. Br J Surg (1991) 0.97

Effect of food on H2-receptor blockade in normal subjects and duodenal ulcer patients. Gut (1990) 0.96

Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96

Tolerance to oral H2-receptor antagonists. Dig Dis Sci (1990) 0.95

The cephalic and gastric phases of gastric secretion during H2-antagonist treatment. Gastroenterology (1991) 0.93

Safety of nonanesthetist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy. Endoscopy (2003) 0.92

Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report. Gastroenterology (1991) 0.92

Loss of acid suppression during dosing with H2-receptor antagonists. Aliment Pharmacol Ther (1990) 0.92

Trophic effect on longterm administration of 16,16-dm PGE2 on the rat gastric and duodenal mucosa. Scand J Gastroenterol Suppl (1982) 0.92

Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole. Gut (1994) 0.91

Effects of prolonged administration of metiamide on serum gastrin, gastrin content of the antrum and gastric corpus, and G-cell population in the rat. Gastroenterology (1979) 0.89

Persistent lack of somatostatin receptors in gastric mucosa of healing ulcers in rats. Gastroenterology (1994) 0.88

Effects of pinaverium bromide and verapamil on the motility of the rat isolated colon. Br J Pharmacol (1985) 0.86

Neutrophil-derived oxidants mediate formyl-methionyl-leucyl-phenylalanine-induced increases in mucosal permeability in rats. Gastroenterology (1989) 0.86

Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Aliment Pharmacol Ther (2001) 0.85

Morphine-like action of enkephalin analog FK 33-824 on motility of the isolated rat colon. J Pharmacol Exp Ther (1981) 0.85

Estimation of the biliary excretion of different cephalosporins utilizing retrograde cholangio-pancreatography (ERCP). Endoscopy (1981) 0.85

Comparison of gastrointestinal loss of alpha-1-antitrypsin and chromium-51-albumin in Ménétrier's disease and the influence of ranitidine. Digestion (1983) 0.85

Sensitivity of the parietal cell to pentagastrin in health and duodenal ulcer disease: a reappraisal. Scand J Gastroenterol (1982) 0.85

[Solitary rectal ulcer]. Schweiz Med Wochenschr (1971) 0.84

Preliminary communication of the effect of Gastrin II on acid secretion in conscious rats with chronic gastric fistula. Gastroenterologia (1966) 0.84

Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumors. Endocrinology (1992) 0.84

Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease. Am J Gastroenterol (1998) 0.84

[Natural causes of peptic ulcer disease (author's transl)]. Schweiz Rundsch Med Prax (1978) 0.83

Lower esophageal sphincter in reflux esophagitis. Scand J Gastroenterol (1976) 0.82

[The histamine and pentagastrin infusion tests. Comparative studies in man (preliminary report)]. Schweiz Med Wochenschr (1968) 0.82

Measurement of cholecystokinin octapeptide-induced motility of rat antrum, pylorus, and duodenum in vitro. Am J Physiol (1983) 0.82

Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine. Gastroenterology (1993) 0.82

Cellular mechanisms, interactions, and dynamics of gastric ulcer healing. J Clin Gastroenterol (1995) 0.82

Indomethacin and turnover of gastric mucosal cells in the rat. Am J Physiol (1986) 0.82

[Ulcer therapy using cimetidine]. Dtsch Med Wochenschr (1978) 0.81

Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2002) 0.81

Multihormonal, amyloid-producing tumour of the islets of Langerhans in a twelve-year-old boy. Clinical, morphological and biochemical data and review of the literature. Virchows Arch A Pathol Pathol Anat (1971) 0.81

Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Gut (1994) 0.81

Substance P activates rat colonic motility via excitatory and inhibitory neural pathways and direct action on muscles. J Pharmacol Exp Ther (1994) 0.81

In vitro tests overestimate in vivo neutralizing capacity of antacids in presence of food. Dig Dis Sci (1985) 0.80

Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity. Aliment Pharmacol Ther (1998) 0.80

The endogenous release of pancreatic polypeptide by acid and meal in dogs. Effect of somatostatin. Scand J Gastroenterol (1978) 0.80

[Gastric acid secretion stimulated by penta-gastrin and insulin in man]. Schweiz Med Wochenschr (1969) 0.80

Mechanism of action of cholecystokinin octapeptide on rat antrum, pylorus, and duodenum. Am J Physiol (1983) 0.80

Simple gastroscopy technique in the rat. Dig Dis Sci (1984) 0.80

Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcer. Dig Dis Sci (1991) 0.79

Interleukin-1 and experimental gastric ulcer healing in the rat. J Physiol Pharmacol (1993) 0.79

Increased responsiveness of gastric mucosa to gastrin stimulation in the Eck fistula rat. Gastroenterology (1974) 0.79

Effect of acid inhibition on the growth of parietal cells. Scand J Gastroenterol Suppl (1986) 0.79

Induction of cyclooxygenase-2 in a rat gastric epithelial cell line by epiregulin and basic fibroblast growth factor. J Clin Gastroenterol (1998) 0.79

Severe pseudomembranous and ulcerative colitis during gold therapy. Endoscopy (1983) 0.79

A comparison between intragastric titration and aspiration technique under basal conditions and after food or pentagastrin stimulation. Am J Dig Dis (1978) 0.79

Smoking and pH response to H2-receptor antagonists. Scand J Gastroenterol (1989) 0.79

Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Gut (1993) 0.79

Gallstone ileus after endoscopic sphincterotomy. Endoscopy (1981) 0.78

The Omega-Project--a comparison of two diagnostic strategies for risk- and cost-oriented management of dyspepsia. Eur J Gastroenterol Hepatol (1997) 0.78

Prophylactic treatment of acute gastroduodenal stress ulceration. Low-dose antacid treatment without and with additional ranitidine. Scand J Gastroenterol (1987) 0.78

Healing dynamics of traumatic gastric mucosal defects in the normal and hyperacid stomach. Dig Dis Sci (1980) 0.78

Both topical and systemic treatments with 16,16-dimethyl prostaglandin E2 are trophic to rat gastric mucosa. Scand J Gastroenterol Suppl (1984) 0.78

pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses. Br J Clin Pharmacol (1992) 0.77

Dyspepsia and Helicobacter pylori: to endoscope or not to endoscope? The Omega-Study Group. Gastroenterology (1996) 0.77

[CT and ERCP as a combination research method in pancreatic diseases]. Rofo (1984) 0.77

[The effect of salmon calcitonin on pancreatic enzymes and hormones before and after retrograde cholangiopancreatography]. Schweiz Med Wochenschr (1981) 0.77

[Frequency of antibiotics-associated colitis in hospitalized patients in 1974-1991 in "Comprehensive Hospital Drug Monitoring", Bern/St. Gallen]. Schweiz Med Wochenschr (1995) 0.77

16,16-Dimethyl prostaglandin E2 stimulates growth and maturation of rat gastric and small-intestinal mucosa. Scand J Gastroenterol Suppl (1984) 0.77

A double-blind trial of loperamide in the treatment of chronic diarrhoea. S Afr Med J (1979) 0.77

[Effect of corticosteroids on gastric acid secretion in rats. Preliminary report]. Schweiz Med Wochenschr (1971) 0.76

Pathophysiology and clinical relevance of Helicobacter pylori. Yale J Biol Med (1994) 0.76

Inhibition of human colon cancer cell growth by antisense oligodeoxynucleotides targeted at basic fibroblast growth factor. Aliment Pharmacol Ther (2001) 0.76

Erythrocyte deformability in dialysed and non-dialysed uraemic patients. Eur J Clin Invest (1982) 0.76

Diagnostic value of biopsy, guided lavage, and brush cytology in esophagogastroscopy. Am J Dig Dis (1977) 0.76

Five-year audit of ambulatory 24-hour esophageal pH-manometry in clinical practice. Scand J Gastroenterol (1999) 0.76

Pharmacokinetics, efficacy and safety of IMMUNATE solvent/detergent (IMMUNATE S/D) in previously treated patients with severe hemophilia A: results of a prospective, multicenter, open-label phase III study. Acta Haematol (2008) 0.76

[Selective pancreatic angiography and retrograde pancreatic cholangiography as a combined examination]. Rofo (1975) 0.76

Timing of bile and acid reflux into the esophagus. Am J Gastroenterol (2002) 0.75

Drugs for bleeding peptic ulcer. Aliment Pharmacol Ther (2002) 0.75

Acid suppression and upper GI bleeding. Aliment Pharmacol Ther (2000) 0.75